Caloric Compensation Index (COMPX) Study for Eating Disorders
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines how mothers and infants interact regarding emotions, feeding, and eating habits. Researchers aim to understand how these interactions might influence a child's diet and body weight. The study tests an approach called COMPX (Caloric Compensation Index) with children already participating in a related long-term study. Families with infants enrolled in the ongoing observational study (NCT06039878) are eligible to join. As an unphased trial, this study provides families with a unique opportunity to contribute to important research on early childhood development and nutrition.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the COMPX model is safe for studying eating behaviors in mother-infant dyads?
Research has shown that the Caloric Compensation Index (COMPX) treatment is generally easy for people to handle. Studies on children's eating and hunger management, integral to the COMPX approach, have not reported any serious side effects.
One study focused on children aged 7 to 9 and found that it helped them control their appetite without negative effects. Another study examined siblings aged 5 to 12 with different weights and also found no harmful outcomes.
Although detailed information about side effects from the COMPX study is limited, these findings suggest that the treatment is safe for children. The emphasis on understanding eating habits and appetite through caloric compensation supports its safety.12345Why are researchers excited about this trial?
Researchers are excited about the Caloric Compensation Index (COMPX) because it takes a novel approach to understanding and potentially treating eating disorders. Unlike traditional treatments that often focus on therapy or medication to manage symptoms, COMPX aims to investigate how the body's natural ability to adjust calorie intake can be used to help manage these disorders. This method could offer a more personalized and potentially more effective way to address eating disorders by tapping into the body's inherent regulatory mechanisms. By exploring this new angle, researchers hope to gain insights that could lead to innovative treatment strategies beyond the current options.
What evidence suggests that the COMPX treatment could be effective for eating disorders?
The Caloric Compensation Index (COMPX), used to assess participants in this trial, measures how well individuals adjust their eating based on previous meals. Research has shown that children naturally regulate their eating by adjusting their intake according to earlier calorie consumption. One study found that children possess a certain level of compensation, meaning they naturally balance their calorie intake throughout the day. Other findings indicate that students' ability to manage food intake relates to their body mass index (BMI), suggesting some self-control over eating habits. This approach aims to better understand eating behaviors and might offer insights into managing eating disorders.23567
Who Is on the Research Team?
Julie Lumeng, MD
Principal Investigator
University of Michigan
Are You a Good Fit for This Trial?
This study is for mother-infant pairs where the child is already part of an ongoing observational study (NCT06039878). It's focused on understanding how emotions, bonding, and eating patterns between a mother and baby are related to feeding habits, the child's eating behaviors, diet, and body fat.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Interventional Task
Children participate in an interventional task to test biobehavioral mechanisms related to emotion, attachment, and nutritive intake
Follow-up
Participants are monitored for safety and effectiveness after the interventional task
What Are the Treatments Tested in This Trial?
Interventions
- COMPX
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Michigan
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator